AzTrials
AzTrials

FitnessNCT03781999

The Effect of a Combination of Orange- and Pomegranate Actives on Physical Fitness in Elderly People

A study testing Actiful in people with Fitness, run by BioActor at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to determine the effect of daily supplementation of a combined orange- and pomegranate extract for a period of 4 weeks on physical fitness compared to placebo. Read more about this study

Who is it for?
Ages 60 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Fitness
What is being tested?
Actiful
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
37 participants
Where
1 siteNetherlands
Study dates
25 Jun 2018to 17 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 60 - 75 years old
  • non smoking
  • BMI 18 -28 kg/m²

Who cannot join

  • Allergy to test product/placebo or citrus fruits
  • BMI lower than 18 or higher than 28
  • Recent muscle injury in less than one month before the start of the study
  • Inability to perform the fitness tests
  • Medical conditions that might influence outcome measure or participant safety during testing, including but not limited to: severe cardiovascular disease, cancer, Parkinson's disease. To be decided by PI.
  • High blood pressure (systolic ≥ 140 mmHg, diastolic ≥ 90 mmHg)
Show all 9Show fewer
  • Use of medication that may interfere with the study results, use of beta-blockers
  • Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
  • Abuse of products; alcohol (> 20 alcoholic units per week) and drugs

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • BioActor

    Maastricht, 6229GS

Other trials in Netherlands

About this study

The primary objective of this study is to determine the effect of daily supplementation of a combined orange- and pomegranate extract for a period of 4 weeks on physical fitness compared to placebo.

In this crossover study, participants will daily receive either a placebo or Actiful®, a supplement containing 500 mg orange extract and 200 mg pomegranate actives, for 4 weeks followed by a wash-out period of 4 to 8 weeks. Subsequently, the second intervention period of 4 weeks (active product or placebo) will take place. The product and placebo will be supplied in capsules that participants can ingest with a glas of water (daily, prior to breakfast).

Read the detailed description

Dietary habits and physical activity are two important components of a healthy lifestyle. Targeted nutritional interventions may improve health and stimulate physical activity. Both orange extracts and pomegranate concentrate have been shown to exert beneficial effects on health and exercise performance. However, the effects of a combination of the two extracts on exercise and physical activity have not been investigated yet. It is expected that this combination may be an effective dietary way to improve exercise performance, physical activity in the free-living state, and quality of life in a middle aged population.

Conditions
Fitness
Being tested
Actiful, Placebo
Keywords
Performance, Polyphenols, Nutrition, Sports

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ActifulDietary supplement

    supplement containing 500 mg orange extract and 200 mg pomegranate actives

  • PlaceboOther

    Maltodextrin

Study groups in NCT03781999
Study groupRoleWhat they receive
ActifulExperimentala supplement containing 500 mg orange extract and 200 mg pomegranate actives
Receives: Dietary Supplement: Actiful
PlaceboPlacebo comparatorMaltodextrin
Receives: Other: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6 Minute Walking Test

    Participants have to walk for 6 minutes, as fast as possible. Total distance will be measured.

    Measured: 0-4-8-12 weeks

Secondary outcomes (4)
  1. Senior Fitness test

    Fitness tests to see if Actiful improves physical activity level

    Measured: 0-4-8-12 weeks

  2. Daily physical activity measured by accelerometers

    Accelerometer is worn for 7 days prior to each testing day

    Measured: 0-4-8-12 weeks

  3. Quality of life questionnaire - WHOQOL-100

    Participants will be asked to fill out the WHOQOL-100 questionnaire to determine quality of life. Scale from 1-5 (disagree-agree)

    Measured: 0-4-8-12 weeks

  4. Concentration of blood marker TAC

    Total antioxidant capacity measurement in plasma

    Measured: 0-4-8-12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2018
  2. Study start25 Jun 2018
  3. Primary completion17 Jan 2019
  4. Study completion17 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03781999
Sponsor's protocol ID
Actiful_001
Status last verified
Jun 2019
First submitted
10 Dec 2018
Last updated
24 Jun 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bednarska K, Fecka I, Scheijen JLJM, Ahles S, Vangrieken P, Schalkwijk CG. A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial. Int J Mol Sci. 2023 Aug 24;24(17):13168. doi: 10.3390/ijms241713168.

    PubMed 37685975

Questions about this trial

What is this clinical trial studying?

A study testing Actiful in people with Fitness, run by BioActor at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6 Minute Walking Test (time frame: 0-4-8-12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03781999, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in